HMGCR Inhibitor Restores Mitochondrial Dynamics by Regulating Signaling Cascades in a Rodent Alzheimer’s Disease Model
Molecular Neurobiology · 2025
DOI: 10.1007/s12035-024-04465-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Neha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Signal Transduction, Mitochondrial Dynamics, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Indian Council of Medical Research, King Saud University, Department of Science and Technology, Ministry of Science and Technology, India.
Themen: Demenz
Abstract (Originalsprache)
Atorvastatin an HMGCR inhibitor may play a role in enhancing spatial and long-term memory and combating anxious behavior deficits induced by Aβ1-42. Behavioral deficit studies, immunoblotting for the antioxidant/apoptotic protein expression, flow cytometry (FACS) for mitochondrial ROS, membrane potential (▲ψm), and histopathological alterations were performed against Aβ1-42 toxicity. Aβ1-42 was infused directly into the brain through i.c.v for the establishment of the AD model. Atorvastatin (ATOR) was administered orally and was used to treat AD in adult male Wistar rats aged between 200 and 250 g. We confirmed that ATOR administration significantly attenuates the Aβ1-42-induced cognitive decline targeted mitochondrial-mediated age-dependent disease progression. Nrf2 stabilizes to interact SOD2 antioxidant enzyme, allowing transcriptional activity by the steep increase in ▲ψm and a reduction in ROS by activating mitochondrial superoxide scavenger and Nrf2-dependent pathway. These findings confirmed that ATOR has the potential efficacy to modulate the interference in cognitive decline induced by Aβ1-42.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, 11451, Riyadh, Saudi Arabia.
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
- Department of Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India. sparvez@jamiahamdard.ac.in.
Förderung
- Indian Council of Medical Research
- King Saud University
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Neha, Pinky, Khan, S. A., Ali, M., Ali, N., Shaquiquzzaman, M., & Parvez, S. (2025). HMGCR Inhibitor Restores Mitochondrial Dynamics by Regulating Signaling Cascades in a Rodent Alzheimer’s Disease Model. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04465-1
Vancouver
Neha, Pinky, Khan SA, Ali M, Ali N, Shaquiquzzaman M, et al. HMGCR Inhibitor Restores Mitochondrial Dynamics by Regulating Signaling Cascades in a Rodent Alzheimer’s Disease Model. Molecular Neurobiology. 2025. doi:10.1007/s12035-024-04465-1
BibTeX
@article{Neha2025,
author = {Neha and Pinky and Khan, Sara Akhtar and Ali, Mubashshir and Ali, Nemat and Shaquiquzzaman, M and Parvez, Suhel},
title = {HMGCR Inhibitor Restores Mitochondrial Dynamics by Regulating Signaling Cascades in a Rodent Alzheimer’s Disease Model},
journal = {Molecular Neurobiology},
year = {2025},
doi = {10.1007/s12035-024-04465-1}
}
EUVIMED